**
Chloe Keys, a 26-year-old from Belfast, has taken a significant step towards reclaiming her health after enduring years of debilitating symptoms caused by large uterine fibroids. Faced with severe menstrual issues and a protracted NHS waiting list, Keys opted for private medical care, reflecting ongoing concerns about women’s health treatment within the public healthcare system.
A Personal Journey Through Pain
Since her teenage years, Keys has been managing Polyendocrine Metabolic Ovarian Syndrome (PMOS), a condition that predisposed her to various reproductive health challenges. In 2022, she discovered the presence of large fibroids, which exacerbated her symptoms, leading to heavy periods, frequent haemorrhaging, and debilitating stomach pain. These issues affected her daily life profoundly; she described occasions where she would leave a “trail of blood” while out in public, underscoring the severity of her situation.
Post-surgery, Keys recounted the physical and emotional toll her condition had taken on her life. “I would be a shell of a human being for half the month during my period,” she stated, noting that her fibroid had grown to the size of a large mango. The distress caused by her symptoms left her housebound, severely anaemic, and battling depression. In her view, the NHS’s response to her condition felt dismissive, prompting her to seek private treatment as a last resort.
Systemic Delays and Frustrations
Keys’s frustrations peaked during a visit to the NHS for a scheduled appointment that was abruptly cancelled. “I waited nine months for this appointment, and they cancelled it while I was sat there in the waiting room,” she recalled, illustrating the emotional strain many patients experience with prolonged waiting times. This incident prompted her to take matters into her own hands, leading to her decision to pursue private surgery.
Despite being encouraged to try an oral medication to shrink her fibroids, which could induce a state of medical menopause, Keys sought alternatives. Her request for surgical intervention was met with resistance, highlighting a disconnect between patient needs and medical recommendations.
Data from a recent survey by women’s health platform Hertility sheds light on the broader issue. Over 90% of respondents reported feeling that their reproductive health concerns were not adequately addressed by healthcare professionals. Moreover, 83% expressed that their worries were frequently dismissed, suggesting a systemic failure in recognising and treating women’s health issues.
Beyond the Personal: A Call for Change
Chloe Keys has emerged as an advocate for better awareness and education surrounding women’s health conditions in the workplace. She emphasized the stigma surrounding menstruation and reproductive health issues, which often lead women to hide their struggles for fear of being perceived as overly dramatic or unprofessional. “I’m sick of having to leave your health conditions at the door,” she asserted, reflecting a sentiment shared by many women in similar situations.
The Hertility 2026 Workplace Report indicates that two-thirds of women experiencing fatigue and anxiety felt their symptoms were trivialised as an unavoidable part of life, only to later receive formal diagnoses. This chronic underestimation of women’s health issues has far-reaching implications, affecting not only individual well-being but also workplace dynamics and productivity.
Institutional Responses and the Path Forward
In response to Keys’s experiences, a spokesperson for Manchester University Foundation Trust expressed regret over the scheduling issues she encountered, acknowledging the frustrations patients face due to waiting lists. They affirmed their commitment to treating patients based on clinical priority, although current statistics indicate that over 7 million individuals are on waiting lists for non-emergency procedures across the UK.
The government’s target of ensuring 92% of patients wait no longer than 18 weeks for treatment is a daunting goal, especially as awareness of conditions like fibroids continues to grow. July is designated as Fibroids Awareness Month, aimed at educating the public about these common yet often overlooked health issues.
Why it Matters
The case of Chloe Keys serves as a poignant reminder of the urgent need for reform in how women’s health is prioritised within the NHS. As systemic delays and dismissive attitudes persist, advocates like Keys are essential in pushing for improved healthcare practices that respect and address the unique challenges women face. Achieving better outcomes in women’s health not only empowers individuals but also enhances overall public health, fostering a society where women’s experiences are validated and treated with the seriousness they deserve.
